NewsHomeNews Search Search Generic Call to Action of Concerned Stakeholders on the implementation of the EU HTA and JCA for ATMPs Read More » July 9, 2024 Generic EU Elections 2024: Call to Action Read More » June 5, 2024 Generic EAHAD-EHA-EHC Joint Support Statement on the EMA draft Guideline Read More » May 29, 2024 Executive Committee EAHAD Statement on Upcoming ISTH Guidelines on Haemophilia Treatment Read More » May 28, 2024 Gene Therapy Cell and Gene Therapy Summit 2024 Read More » April 1, 2024 EAHAD Academy EAHAD Gene Therapy Webinar: Global distribution of gene therapy Read More » March 25, 2024 Congress 2024 EAHAD Research Grants cycle now open Read More » March 6, 2024 Congress EAHAD 2024 Press Release Read More » February 27, 2024 E-Learning Join us for the second E-Learning Live Discussion on EAHAD Academy on 26 October Read More » October 12, 2023 Congress Join the EAHAD 2024 Social Media Ambassadors Programme Read More » September 29, 2023 Generic EAHAD Annual Report 2022 Read More » September 12, 2023 Gene Therapy Relevance of anti-AAV antibodies testing in haemophilia GT Webinar Read More » September 4, 2023 « Previous Page1 Page2 Page3 Page4 Page5 Next »
Generic Call to Action of Concerned Stakeholders on the implementation of the EU HTA and JCA for ATMPs Read More » July 9, 2024
Executive Committee EAHAD Statement on Upcoming ISTH Guidelines on Haemophilia Treatment Read More » May 28, 2024
EAHAD Academy EAHAD Gene Therapy Webinar: Global distribution of gene therapy Read More » March 25, 2024
E-Learning Join us for the second E-Learning Live Discussion on EAHAD Academy on 26 October Read More » October 12, 2023
Gene Therapy Relevance of anti-AAV antibodies testing in haemophilia GT Webinar Read More » September 4, 2023
